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Stabilizing Off-pathway Oligomers 
by Polyphenol Nanoassemblies for 
IAPP Aggregation Inhibition
Praveen Nedumpully-Govindan1, Aleksandr Kakinen2, Emily H. Pilkington2, 
Thomas P. Davis2,3, Pu Chun Ke2 & Feng Ding1
Experimental studies have shown that many naturally occurring polyphenols have inhibitory effect on 
the aggregation of several proteins. Here, we use discrete molecular dynamics (DMD) simulations and 
high-throughput dynamic light scattering (DLS) experiments to study the anti-aggregation effects of 
two polyphenols, curcumin and resveratrol, on the aggregation of islet amyloid polypeptide (IAPP or 
amylin). Our DMD simulations suggest that the aggregation inhibition is caused by stabilization of small 
molecular weight IAPP off-pathway oligomers by the polyphenols. Our analysis indicates that IAPP-
polyphenol hydrogen bonds and π-π stacking combined with hydrophobic interactions are responsible 
for the stabilization of oligomers. The presence of small oligomers is confirmed with DLS measurements 
in which nanometer-sized oligomers are found to be stable for up to 7.5 hours, the time frame within 
which IAPP aggregates in the absence of polyphenols. Our study offers a general anti-aggregation 
mechanism for polyphenols, and further provides a computational framework for the future design of 
anti-amyloid aggregation therapeutics.
Aberrant aggregation of proteins into insoluble amyloid fibrils is implicated in a number of diseases including 
Alzheimer’s, Huntington’s and Parkinson’s diseases, and type-2 diabetes (T2D)1. Even though the aggregating 
proteins associated with these diseases are diverse in terms of their sizes, primary, secondary and tertiary struc-
tures, the corresponding amyloid aggregates display common features such as the characteristic cross-β struc-
ture of fibrils and cytotoxicity caused by either fibrils or intermediate oligomers, suggesting a common amyloid 
mechanism1. Among known amyloidogenic proteins and peptides, T2D-associated human islet amyloid polypep-
tide (hIAPP, a.k.a. amylin) is one of the most aggregation-prone peptides, which spontaneously forms amyloid 
aggregates in vitro within hours at μ M concentrations2. IAPP is co-synthesized, co-stored and co-secreted with 
insulin by pancreatic β -cells, and has functions related to the control of gastric emptying and glucose intake3,4. 
Accumulating experimental evidence suggests that the amyloid aggregates of hIAPP are associated with β -cell 
death in T2D. Hence, inhibition of aggregation is a promising therapeutic approach against T2D as well as other 
amyloid diseases5,6.
Amyloid aggregation is initiated with the nucleation of aggregation seeds from unfolded or unstructured 
monomers and subsequently proceeds rapidly with the elongation of amyloid fibrils. Therapeutic strategies have 
been designed to target various species along the amyloid aggregation pathway. For example, proteins such as 
transthyratin (TTR) and superoxide dismutase 1 (SOD1) form native homo-oligomers; stabilization of these 
functional oligomers by small molecule binding reduces the availability of protein monomers necessary for amy-
loid aggregation formation6–8. Similarly, stabilization of protein monomers from misfolding and self-association 
can effectively prevent amyloid aggregation, which can be achieved by binding with ligands of proteins, antibod-
ies, small molecules or ions9,10. Based on the hypothesis that soluble oligomers rather than insoluble amyloid 
fibrils are toxic, small molecules promoting fibril formation have been exploited to reduce amyloid cytotoxicity11. 
Molecules, which form colloid aggregates and sequester protein monomers to form large non-amyloid aggregates, 
have been categorized as colloidal inhibitors12.
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Another attractive set of amyloid aggregation inhibitors are small molecule polyphenols such as EGCG13, 
curcumin14,15, and resveratrol16, which reduce aggregation and the related cytotoxicity of not only hIAPP14,15,17–23 
but also other proteins and peptides such as amyloid- β 24–27. Polyphenols have the advantage that they are nat-
urally occurring, and non-toxic at moderate concentrations. Despite the known therapeutic benefits of small 
molecules28, pharmacological use of these polyphenols is often limited due to some common issues, such as 
their low water solubility and toxicity at high concentrations. Furthermore, the molecular mechanism of their 
anti-aggregation effect remains elusive, preventing the design of new or modified drug candidates. Therefore, it is 
highly valuable to uncover the inhibition mechanisms of these anti-amyloid small molecule polyphenols.
Several studies have focused on understanding the anti-aggregation mechanisms of small molecule polyphe-
nols. For example, ion mobility spectrometry-mass spectrometry experiments showed that EGCG exerted an 
inhibitory effect on hIAPP aggregation, through direct binding of EGCG to the peptide20 and formation of 
off-pathway oligomers13. Computational modeling has also been applied to bridge the gaps of time and length 
scales between experimental observations and the underlying molecular systems. Using replica exchange simu-
lations of the amyloidogenic segment of hIAPP, resveratrol was found to bind and prevent the lateral growth of 
the fibril-like β -sheets29. In another work, resveratrol was found to bind weakly to IAPP and reduce inter-peptide 
contacts30. A recent computational study showed that resveratrol altered the structure of an hIAPP pentamer31, 
which was modeled by the amyloid fibril structure derived from solid state NMR32. Despite multitudes of these 
studies, the molecular mechanism of inhibition remains largely unknown.
In this work, we applied atomistic discrete molecular dynamics (DMD) simulations to investigate the molecu-
lar mechanism of the inhibitory effects of two anti-aggregation molecules: curcumin and resveratrol. Interestingly, 
an early experimental study reported that aspirin, a structural derivative of phenol, had an inhibitory effect on 
IAPP aggregation33, however, no inhibition by aspirin was found in later studies by two different groups20,34. As a 
control, we also studied the effect of aspirin on hIAPP aggregation. DMD simulations feature rapid sampling of 
conformational dynamics and also accurate modeling of interactions important for protein folding and aggrega-
tion35,36, allowing the examination of large molecular systems with long time scales. We have employed a multi-
scale approach by combining atomistic and coarse-grained DMD simulations to study the protofibril formation 
of SOD137. Recently, we have employed DMD simulations to model the self-association and oligomer formation 
of IAPP and to study the effects of insulin and ions on hIAPP aggregation (ref 9. and Nedumpully-Govindan et al., 
unpublished data). Here we performed unbiased DMD simulations of molecular systems consisting of up to eight 
hIAPP monomers and sixteen small molecules, and showed that the polyphenols stabilized small hIAPP clusters 
via nanoscale assembly, thereby preventing or slowing down further aggregation of hIAPP. Our predictions were 
validated by direct solution measurements using high-throughput dynamic light scattering (DLS), where resvera-
trol was found to stabilize nano-sized hIAPP/resveratrol complexes, inhibiting amyloid aggregation. In our DMD 
simulations, we found that the nanoassemblies were consisted of a hydrophobic core of polyphenol molecules 
structurally reinforced by surrounding proteins. The clusters were stabilized by π -π stacking of the aromatic 
groups of the proteins and polyphenol molecules as well as hydrogen bonds between the hydroxyl groups of the 
polyphenols and the protein backbones or sidechains. Our study has revealed, for the first time, the atomistic 
details of inhibitor-induced off-pathway oligomer formation of amyloid proteins. This new insight may prove 
highly beneficial to the rational design of alternative nanoassembly inhibitors.
Results
Self-assembly of small molecules. We first simulated the self-assembly of small molecules by randomly 
placing 16 aspirin, curcumin or resveratrol molecules in a box (see Methods for details). Ten independent simula-
tions with different initial conditions were performed. We found that the two polyphenols, curcumin and resvera-
trol, self-assembled into large aggregates while aspirin favored to remain as monomers (Fig. S1). We analyzed the 
steady states reached by the three species, and found that the probability of finding a monomer (Fig. S1B) is the 
highest for aspirin, followed by resveratrol and curcumin. This is in the same order as the solubility of the small 
molecules. Specifically, aspirin is highly water soluble (solubility ~17 mM), whereas curcumin and resveratrol 
possess solubility of ~1.6 μ M38 and ~131 μ M39, respectively. The probability of finding a 16-mer is, however, also 
higher for resveratrol than curcumin, which is zero for aspirin.
Curcumin and resveratrol show high propensity to IAPP monomers than aspirin. We next simulated systems 
consisting of a single IAPP peptide and two small molecules. The effective ratio of the small-molecules to IAPP 
typically varied from 1 to 10 in experiments20, and hence we chose an intermediate ratio of 2 in our simulations. 
Examination of the simulation trajectories indicated that the binding behavior of aspirin with IAPP was different 
from that of polyphenols curcumin and resveratrol. Specifically, the two individual polyphenol molecules were 
often paired with each other and strongly bound to the peptide (representative snapshot structures of the simula-
tions in Fig. 1A,B). However, aspirin molecules showed a very low affinity for binding with each other or with the 
peptide (Fig. 1C). The observed differential binding with IAPP by different small molecules is probably because of 
the difference in hydrophobicity. Due to their relatively high hydrophobicity, curcumin and resveratrol are likely 
to self-associate or bind to the hydrophobic residues of the peptide. To validate this hypothesis, we calculated the 
average number of atomic contacts (Supplementary Fig. S2) and contact frequency (Fig. 1D) of the small mole-
cules with each IAPP residue. Examination of simulations indicated that all hIAPP monomer simulations reached 
their equilibrium or steady states rapidly (~10 ns) due to the small system sizes (data not shown). As discussed 
later, even the largest simulated systems reached their steady states by half of the simulation time (~25 ns). Hence, 
for consistency all reported averaging were carried out over the last half of trajectories, and over ten independ-
ent simulations. Two atoms within 5.5 Å were counted as an atomic contact, while a residue having at least one 
atomic contact with a ligand was defined as a contact. We found that the two polyphenols indeed showed high 
probability for binding the hydrophobic residues Leu12, Phe15, His18, Phe23, Leu27 and Tyr37. In comparison, 
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aspirin made considerably fewer contacts with the protein than either curcumin or resveratrol. We also calculated 
the total peptide-binding time of the small molecules and found that, while aspirin bound ~57% of the time, the 
polyphenols bound the peptide during ~99% of the time. The small size and low affinity of aspirin to bind IAPP 
as a dimer may also have contributed to its particularly low binding frequency as shown in Fig. 1D. Even though 
aspirin’s affinity to bind IAPP residues was smaller than that of polyphenols, the dynamic binding with residues 
10–30 (Fig. 1D) increased the corresponding probability to form helices (Fig. 1A,E).
We further examined the secondary structure contents of the peptide in the presence and absence of 
small-molecule binding (Fig. 1E). In the control simulations without any small molecules, the peptide was mostly 
unstructured with about 7 residues forming an α -helix and 11 residues forming a β -strand, in agreement with 
previous in vitro and computational studies2,9,40. An increase in the helix content and decrease in the β -strand 
content were observed in the presence of all three types of small molecules. Even though binding of aspirin to 
IAPP was weaker than polyphenols, it exerted the strongest influence on the α -helix and β -strand contents of the 
peptide. No significant changes of the turns or coils were caused upon small molecule binding. To evaluate the 
formation of tertiary structures, we also computed residue pair-wise contact frequency map of IAPP monomer 
with and without small-molecule binding (Fig. S3). In the absence of ligands, IAPP monomer did not have sig-
nificant long-range tertiary contacts, except the disulfide-bond related interactions at the N-terminal and a weak 
antiparallel interaction with a turn near residues 20–23 (Fig. S3A). The weak long-range antiparallel interaction 
was disrupted by all three small molecules (Fig. S3B–D).
Curcumin and resveratrol reduce self-association of IAPP. To understand the effect of small-molecule binding 
on the self-association of multiple peptides, we performed DMD simulations with 2, 4, 6 and 8 IAPPs, where the 
IAPP to small molecule ratio (1:2) and the peptide density was kept unchanged from those in the monomer simu-
lation. Since the amyloid aggregates are rich in inter-peptide β -sheets, we expect the probability of amyloid nucle-
ation to be correlated with the number of inter-chain contacts. Thus, for each set of multi-IAPP simulations, we 
calculated the total inter-chain IAPP contacts averaged over ten independent trajectories (Fig. 2A). As expected, 
as the number of IAPPs increased, the total number of inter-peptide contacts increased. The contact numbers in 
Figure 1. Interaction of small molecules with IAPP monomer. (A–C) Representative snapshots showing the 
final structures from simulations with (A) aspirin, (B) curcumin and (C) resveratrol. (D) Contact frequency 
of small molecules with IAPP residues. The IAPP-small molecule contact is dominated by the hydrophobic 
residues. (D) Small molecules stabilize helices while the β -strand content of IAPP is reduced.
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IAPP-aspirin binding simulations were indistinguishable from the control simulations (peptides alone), suggest-
ing that aspirin had little effect on IAPP self-association. Along with the weak affinity of aspirin for IAPP mono-
mer (Fig. 1), our simulation results are consistent with the latest experimental observation that aspirin had little 
inhibitive effect on IAPP aggregation20,34. In contrast, in the presence of curcumin and resveratrol the peptide 
chains made fewer contacts with each other. Also, curcumin displayed a stronger effect on reducing IAPP-IAPP 
contacts than resveratrol. We also calculated the number of atomic contact between amyloidogenic residues of 
IAPP, residues 22–29 (Supplementary Fig. S4). This segment alone can form fibrils in vitro, and is believed respon-
sible for the high amyloidogenic propensity of human IAPP41,42. Similarly, the amyloidogenic contact number was 
Figure 2. Interactions of small molecules with multiple IAPPs. (A) IAPP-IAPP contact number as a function 
of number of IAPP chains. The contact number is smaller in the presence of curcumin and resveratrol, while 
aspirin has no apparent effect. (B) Secondary structure contents for the octamer IAPP system. The overall 
number of helical residues is increased in comparison with the monomer IAPP system. Also, the small 
molecules have an opposite effect on the helical and strand contents of IAPP. (C) Typical trajectories of potential 
energy and IAPP-curcumin contact number for the octamer IAPP system. Snapshots of the system at different 
times are shown in the inset of (C). Representative final snapshots of IAPP systems with (D) resveratrol,  
(E) aspirin and (F) no ligand.
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also smaller in the presence of polyphenols in comparison with simulations of peptide alone or peptide with aspi-
rin binding (Supplementary Fig. S4). Hence, DMD simulations suggest that polyphenols inhibit IAPP aggregation 
by a reduction of the inter-peptide association, thereby reducing the probability for the peptides to nucleate the 
formation of fibrils, while aspirin did not show this effect.
To evaluate whether the binding of small molecules leads to any structural changes of the peptides, we first cal-
culated the secondary structure contents per IAPP chain with and without small molecules binding (e.g. Fig. 2B, 
simulation of eight IAPPs). Firstly, in the absence of small molecules, the peptides were significantly more helical 
than IAPP monomers. This observation is in agreement with several experimental studies in which α -helix rich 
intermediate states have been reported42–45. The presence of helical intermediates have also been observed en 
route to the aggregation of a number of other peptides and it has been hypothesized that helix-helix interaction 
plays a key role in aggregation46. The helices formed by IAPP were amphiphilic and only marginally stable in 
solution (helical propensity of each residues shown in Supplementary Fig. S5). In the absence of small molecules, 
the associations between such helices stabilized them to increase the helix content. Binding of small molecules 
with peptide monomers had a similar stabilizing effect of helices, but to a lesser extent (Fig. 1E). In the presence of 
both aspirin and polyphenols, we found that relatively smaller number of residues formed helices (Fig. 2B). Our 
results suggested that the peptides in the IAPP-small molecule complexes were likely stabilized by the interactions 
between peptides and small molecules rather than peptide-peptide interactions. We calculated the inter-peptide 
contact frequency between all pair-wise residues (Fig. S6). In the absence of small molecules, the inter-peptide 
quaternary interactions were dominated by the N-terminal residues near Phe15 and His18 and the amyloidogenic 
region (Fig. S6A). Consistent with the total number of inter-peptide contact number, aspirin showed no signifi-
cant effect on contact map (Fig. S6B). In the presence of curcumin and resveratrol, the overall quaternary contact 
was reduced (Fig. S6C–D). Especially, the inter-peptide interactions mediated by residues Phe15 and His18 were 
lost, which instead formed interaction with the polyphenols. Our results highlight the importance of N-terminal 
aromatic residues Phe15 and His18 for the self-association and aggregation of IAPP.
Polyphenols engender nano-sized clusters of IAPPs. To address how polyphenols reduce the total inter-peptide 
contacts, we examined the simulation trajectories (e.g. a simulation of eight IAPPs with 16 curcumin molecules 
in Fig. 2C). As the simulation progressed, the initially separated peptides and curcumins started to aggregate and 
form a few clusters (see the inset of Fig. 2C). Similarly, simulations with resveratrol also often resulted in multi-
ple IAPP-ligand clusters, each consisting of a few peptides (Fig. 2D). In contrast, in the absence of polyphenols 
(peptides alone or with aspirin) the peptides aggregated into a single large cluster (Fig. 2E,F), in agreement with 
a previous experimental study47. Therefore, our results indicate that polyphenols can reduce the total number of 
contacts between IAPPs by forming smaller clusters.
To characterize these IAPP clusters formed in the simulations, we first identified the protein-containing clus-
ters from DMD simulations of eight IAPP peptides. A peptide molecule or a small molecule belonged to a cluster 
if it made at least one atomic contact with a member molecule within the cluster. For all simulations, we used the 
second half of all independent simulations (where the systems were already equilibrated as shown by the time 
evolution of potential energies and inter-molecular contacts in Fig. 2C and number of clusters in Fig. S7) and 
characterized the clustering behavior by calculating the number and size of clusters, as well as the composition 
of each cluster. We first computed the histograms of the number of clusters (Fig. 3A). In the absence of small 
molecules, eight IAPP chains tended to aggregate into 1-2 clusters. In the presence of aspirin, IAPP displayed a 
very similar aggregation profile, again suggesting a weak effect of aspirin on IAPP aggregation. In the presence 
of resveratrol and curcumin, the IAPPs started to form more clusters. Especially with resveratrol, the IAPPs dis-
played a high preference to form three clusters.
Additionally, we computed the mass-weighted histogram of the cluster size (the number of protein chains 
in the cluster), which estimated the probability of each peptide to form a cluster of a given size (Fig. 3B). In the 
absence of small molecules, peptides alone tended to aggregate into a single octamer cluster. A second peak 
corresponding to an IAPP hexamer cluster was also observed but was significantly smaller than the octamer 
peak. Similarly, an IAPP octamer was also the dominant cluster in the presence of aspirin, followed by an IAPP 
pentamer. Noticeably, in the presence of resveratrol a peptide showed the highest probability to aggregate into 
pentamers, while in the presence of curcumin clusters consisting of three IAPPs were the most common, which is 
closely followed by the octamer. To further characterize these clusters induced by polyphenols, we analyzed their 
compositions, i.e., the numbers of peptides and small molecules. We calculated the heat-map of clusters denoted 
by the number of small molecules versus the number of peptides (Fig. 3C,D). We found that there was an overall 
ratio of 2:1 between small molecules and peptides for the clusters, which is determined by the molar ratio used in 
the simulations. On the other hand, analysis indicates that the oligomers were molecular complexes composed of 
both small molecules and peptides. The clustering analysis of our simulations suggests that polyphenols curcumin 
and resveratrol enabled the formation of stable oligomers composed of a relatively small number of peptides and 
small molecules, in drastic contrast to the aggregate state of large clusters by peptides alone.
Polyphenols form the core while IAPPs participate in the “corona” of the nano-assembled oligomer. We char-
acterized the most stable clusters formed in the presence of small molecule phenols, namely IAPP trimers for 
curcumin and IAPP pentamers for resveratrol (Fig. 3B). We isolated these oligomers from the simulation tra-
jectories and generated the corresponding ensembles. Representative structures of small-molecule-induced oli-
gomers (inset of Fig. 4A,B) suggest that the small molecules were positioned inside and peptides outside. To verify 
this observation, we computed the radial distribution of the peptide and small molecule atoms as a function of 
the distance from the center of mass of a cluster, averaged over the structural ensemble of corresponding oli-
gomers (Fig. 4A,B; and the corresponding density profiles in Supplementary Fig. S8). Indeed, in both cases, the 
small molecules were buried inside the oligomer with its peak 9–10 Å away from the center of mass, while the 
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distribution of the protein atoms was shifted to the right. The peak of protein atom distribution is 14–15 Å for the 
curcumin-binding-induced trimers, and 16-17 Å for the resveratrol-induced pentamers. We can also see from 
the insets of Fig. 4A,B that many hydroxyl groups of the polyphenols were exposed (red spheres in Fig. 4A,B). 
Therefore, we further computed the radial distributions of aliphatic carbon and oxygen atoms of the small mole-
cules inside the oligomer (Fig. 4C,D). We found that the aliphatic carbons of both curcumin and resveratrol were 
distributed closer to the core than the hydrophilic oxygen atoms. Thus, the small molecule polyphenols inside the 
cores of the oligomers had their hydrophobic atoms buried inside and hydrophilic hydroxyl groups outside. In 
comparison, in the presence of aspirin the IAPP octamer (Fig. 2E, corresponding to the highest peak in Fig. 3B) 
and pentamer structure (e.g., a snapshot structure in Fig. S9, corresponding to second peak in Fig. 3B) had no 
core formed by small molecules. Aspirin molecules either stayed unbound or bound individually to the surface 
of oligomers.
Dynamic light scattering measurements. Other experimental studies have reported the existence of small spher-
ical IAPP aggregates in the presence of resveratrol using surface measurements by atomic force microscopy 
(AFM)17,48. The sizes of these structures were consistent with the small molecular weight oligomers observed 
in our DMD simulations. For proof of concept we carried out an independent solution measurement using 
high-throughput DLS to characterize the size distribution of IAPP in the presence and absence of resveratrol. 
Curcumin was not included in the DLS experiment due to its much poorer water solubility, which is two orders 
of magnitude lower than that of resveratrol. As expected, the DLS measurement revealed a rapid assembly of 
IAPP at 19 μ M in Milli-Q water into large fibrils over a time course of 450 min (Fig. 5A). Specifically, at time zero 
when the experiment just began, the IAPP control displayed a pronounced peak value (86.5% mass) of hydrody-
namic diameter at 2.2 ± 0.7 nm, approximately the size of a monomer, accompanied by a small peak at 30.4 nm 
(10.5% mass). At the time point of 45th min, the most pronounced peak of the protein (66.2% mass) was shifted 
and broadened to 31.3 ± 3.2 nm, alongside two other major peaks at 238.5 nm (12.5% mass) and 5,936.5 nm 
Figure 3. Clustering properties of the octamer IAPP system. (A) The probability of the number of IAPP-
containing clusters. For IAPP alone and IAPP-aspirin systems one or two clusters are most populated while 
three clusters is most populated for IAPP-resveratrol and IAPP-curcumin systems. The error bars correspond 
to standard deviations from independence simulations. (B) Histogram of the cluster size. Three and five 
IAPP-containing clusters are most populated for curcumin- and resveratrol-IAPP systems, while eight IAPP-
containing cluster is the most common one for IAPP alone and IAPP-aspirin systems. (C,D) Compositions heat 
map for IAPP-curcumin and IAPP-resveratrol clusters.
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(21.4% mass), respectively. Further incubation of the protein at room temperature saw its major peaks rose to 
46.3 ± 3.7 nm (49.5% mass) and 2,766.4 nm (44.2% mass) at time point of 210th min, 60 ± 6.6 nm (74.4% mass) 
and 761.5 nm (19.3% mass) at time point of 360 min, and 65.1 ± 4.9 nm (44.8% mass) and 3,451.1 ± 93.6 nm 
(47.5% mass) at time point of 450 min, indicating an irreversible process of amyloid fibrillation.
In the presence of resveratrol, however, the process of IAPP fibrillation came to a halt, as clearly shown by 
the evolution of the protein hydrodynamic diameter in Fig. 5B–D. The resveratrol control at 39 μ M registered 
no distinct peaks as expected, ensuring repeatability of the DLS experiment. In contrast to the IAPP control, 
the single and major peak of the hydrodynamic diameter ranged between 1.7~2.7 (± 0.5) nm, 1.5~4.2 (± 0.8) 
nm and 1.8~4.2 (± 1.0) nm for the IAPP/resveratrol molar ratio of 1:2, 1:2.7 and 1:3.1, respectively (Fig. 4B–D). 
This result is in good agreement with the DMD observation that each IAPP pentamer encased multiple hydro-
phobic resveratrol molecules to render small clusters of (Figs 3,4 and Supplementary Fig. S4), thereby disrupting 
amyloid fibrillation. This result further suggests that excess supply of resveratrol – whose concentration was still 
below its solubility – did not significantly destabilize the IAPP-resveratrol clusters. These excess small molecules 
either stayed dissolved in the solution, or were partitioned into the hydrophobic cores of the IAPP pentamers or 
higher-order assemblies, as reflected by the comparable but slightly increased hydrodynamic diameters observed 
for IAPP/resveratrol molar ratios of 1:2.7 and 1:3.1 than 1:2.
Discussions
A number of experimental studies have reported the inhibitory effect of curcumin and resveratrol on IAPP aggre-
gation14,15,17,18, but the studies on the effect of aspirin on IAPP aggregation do not converge20,33,34. According to our 
atomistic DMD simulations, polyphenols curcumin and resveratrol bound IAPP monomers strongly and reduced 
self-association of IAPP by stabilizing IAPP oligomers of small molecular weights. On the other hand, aspirin 
showed weak binding to IAPP monomer and exerted little effect on the self-association of IAPPs. Therefore, our 
simulations support the scenario20,34 that aspirin has little inhibitory effect on IAPP aggregation. The reported 
inhibitory effect in the earlier study33 was probably due to the interference of aspirin with the Congo-red assay 
that was used to monitor amyloid fibril formation of IAPP, as noted in ref. 34.
Figure 4. Properties of stable small molecule-IAPP clusters. (A,B) Radial distributions of IAPP and small 
molecule atoms from the center of mass of the cluster, for (A) curcumin-IAPP and (B) resveratrol-IAPP 
clusters. Typical structures of the clusters are shown in inset; protein atoms in golden-yellow, curcumin in 
green (carbon) and red (oxygen), and resveratrol in blue (carbon) and red (oxygen). (C,D) Distributions of 
small aliphatic carbon and oxygen atoms of curcumin and resveratrol inside the clusters. (Inset) Structures of 
curcumin and resveratrol, highlighting the oxygen atoms used for calculations as spheres.
www.nature.com/scientificreports/
8Scientific RepoRts | 6:19463 | DOI: 10.1038/srep19463
For many amyloidogenic proteins such as amyloid-β and α -synuclein, experimental studies identified signifi-
cant small oligomer intermediates populated along the aggregation pathway49–52. Our DMD simulations of multi-
ple IAPP alone suggested that the peptides tend to form a single large aggregate (Fig. 3B). Despite a high peptide 
concentration (~ 6 mM) in our simulations, such a tendency of IAPP forming large aggregate was reported by 
previous NMR and sedimentation velocity studies47,53. Different groups reported the accumulation of α -rich 
intermediate states of IAPP before the formation of β -rich IAPP fibrils42–45. Our control simulations of multiple 
IAPPs captured the increase of α -helixes compared to the simulation of IAPP monomer (Fig. 2). The increase 
in helical content upon initial association was due to the stabilization of marginally stable helices by inter-chain 
interactions. In the presence of curcumin or resveratrol, IAPPs showed a reduction of helical content with a 
corresponding small increase in β -strand and random coil structures (Fig. 2). This observation is consistent with 
a reported experimental study of the effect of curcumin on IAPP aggregation14, where circular dichroism (CD) 
revealed the decrease of α -helix when IAPPs were incubated with curcumin. Therefore, our computational stud-
ies are able to recapitulate the secondary structure contents of IAPP under various experimental conditions.
Raleigh and coworkers applied point mutations to analyze the interaction of resveratrol with IAPP18. 
Accordingly, residues Phe15, His18 and Tyr37, and possibly Arg11 were the most important residues for 
resveratrol-IAPP interactions. According to our simulations, residues that make significant contact with resver-
atrol (and also with curcumin) were Arg11, Phe15, His18, Phe23, Leu27 and Tyr37 (Fig. 1D and Supplementary 
Fig. S1). Thus the simulations and mutagenesis studies converge on the roles of residues Arg11, Phe15, His18 
and Tyr37, but not Phe23. Interaction of Leu27 with small molecules has not been studied in the experiment. As 
also noted by Tu et al.18, solid-state NMR structure of IAPP fibrils indicated that Phe23 was positioned in a loop 
connecting the two β -strands, while the other residues were positioned in the β -strands. Even if resveratrol bound 
Phe23, it may not exert a strong effect on the IAPP aggregation process, and hence mutation of this particular 
residue may not show any significant effect on the aggregation-inhibition by resveratrol.
In addition to mutagenesis assays, atomic force microscopy (AFM) has been used to study the morphology 
of IAPP aggregation. In the presence of resveratrol, AFM measurements reported the absence of IAPP fibrils, 
while detected the existence of small spherical structures with diameters of ~3–4 nm17, in agreement with our 
DLS measurement (Fig. 5B–D). Similar spherical structures have also been observed in a synchrotron X-ray 
reflectivity study in the inhibition of lipid membrane-induced IAPP aggregation by resveratrol48. Inhibition of 
protein aggregation by a colloidal mechanism — molecules form colloids and sequester proteins — has been 
reported in the past12,20. However, the sizes of colloids in this case are much larger than that of the small clusters 
of IAPP stabilized by polyphenols. In our DMD simulations, we observed the formation of small IAPP oligomers, 
which have a diameter of ~4 nm (see Fig. 4 and Supplementary Fig. S4), closely matching with the experimentally 
observed IAPP cluster radius. Although AFM might have limitations to capture the structures of these oligomers 
in solution, our computational and DLS studies together with the AFM measurements in the literature strongly 
support the formation of small IAPP oligomers in the presence small molecules.
Many polyphenols have been found to have anti-aggregation effects on IAPP as well as some other amyloi-
dogenic peptides, such as Aβ in Alzheimer’s disease. Our DMD simulations of two model molecules, curcumin 
Figure 5. Time evolution of the hydrodynamic diameters of IAPP (A) and IAPP-resveratrol at 1:2, 1:2.7 and 
1.3.1 molar ratios (B–D). IAPP concentration in all samples: 19 μ M.
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and resveratrol, suggest a common mechanism – these polyphenols can stabilize the formation of off-pathway 
oligomers where the small molecules self-assemble in a nano-sized core and IAPP peptides bind to the periph-
eries. To evaluate how the small molecular clusters stabilized the formation of IAPP oligomers, we examined the 
interactions between the small-molecule core and the bound IAPP peptides (Fig. 6). Remarkably, the phenyl 
groups of the small molecules formed π -π stacking with the aromatic side chains of the peptides. In addition, we 
also observed extensive hydrogen bond formation between the hydroxyl groups of the polyphenols and the pep-
tide backbones or side chains (magenta dashed lines in Fig. 6). Therefore, π -π stacking and hydrogen bonding, 
characteristic interactions associated with the phenol moiety, were important for the hetero-molecular complex 
formation. The aromatic side chains, especially Phe15, strongly influenced and contributed towards IAPP aggre-
gation42,54. Our simulation of IAPP alone also highlighted the importance of Phe15 in the peptide self-association 
and aggregation (Fig. S6A). When the residue takes part in π -π stacking with polyphenols, inter-chain inter-
actions of aromatic residues will be affected. In this study, we used a small IAPP:small molecule ratio of 1:2 
(1:2 – 1:3.1, in experiments).
The aggregation inhibitors can be strongly affected by the inhibitor concentration, e.g. as shown in the case 
of amyloid-β 55. Similarly, the relative and absolute concentrations of both IAPP and small molecules may influ-
ence the inhibition efficiency and mechanism as well as the structure and composition of oligomers. Here, we 
focused on the inhibition mechanisms by different types of small molecules. The concentration dependence of 
aggregation inhibition by small molecules required further systematic investigations both computationally and 
experimentally. Similarly, membrane disruption by amyloid aggregates is believed to be the prime cause for cyto-
toxicity56. It will be of great interest to study whether polyphenols also inhibit membrane disruption by IAPP.
Conclusions
We applied atomistic DMD simulations to uncover the anti-aggregation mechanism of two polyphenol molecules, 
curcumin and resveratrol, which have been experimentally found to inhibit IAPP aggregation. For comparison, 
we also studied aspirin, whose anti-aggregation effect is not conclusive20,33,34. Our simulations suggest that both 
curcumin and resveratrol could bind IAPP monomer strongly, but aspirin had a weaker binding to the peptide. 
Further simulations with multiple peptides and small molecules revealed that the anti-aggregation effects of these 
polyphenols were not due to the stabilization of IAPP monomers as in the aggregation inhibition by insulins9,42, 
but resulted from stabilization of off-pathway oligomers, a conclusion corroborated by the high-throughput DLS 
measurement of IAPP exposed to resveratrol. In the control simulations with peptides alone and in the presence 
Figure 6. Stabilizing forces of small molecule-IAPP clusters. (A) Curcumin-IAPP and (B) resveratrol-IAPP 
clusters are stabilized by π -π stacking and hydrogen bonds. Zoomed-in snapshots depict stacking of phenyl 
groups of the small molecules against that of the protein. The hydroxyl groups of the small molecules make 
hydrogen bonds with the protein backbones and side chain atoms (shown using magenta dashed lines).
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of aspirin, we found that the peptides were prone to continuously self-associate into large oligomers. In con-
trast, polyphenols like curcumin and resveratrol nucleated the formation of stable oligomers with smaller molec-
ular weights, e.g. trimers and pentamers induced by curcumin and resveratrol, respectively. Detailed analysis 
suggested that multiple polyphenol molecules formed the core, which provided both hydrophobic surfaces and 
hydrogen binding acceptors and donors (hydroxyls in the phenol groups) for peptides to bind. By burying the 
hydrophobic residues and unsatisfied hydrogen bonds inside, the oligomers were stable and did not continuously 
grow as in the case of the simulations for the case of peptides alone. The difference between curcumin and resver-
atrol in their physicochemical properties, such as geometry, conformational flexibility, and molecular weight, 
determined the formation of distinct oligomers. Further studies combining DMD simulations and experimental 
characterizations will help design optimal anti-aggregation small molecules to inhibit IAPP aggregation in T2D.
Methods
DMD Simulations. Simulations were carried out using discrete molecular dynamics (DMD) algorithm35,36. 
In DMD the inter-atomic interactions have similar components as conventional molecular mechanics force fields, 
but the interactions are modeled using discrete potential functions mimicking the continuous potential functions. 
The simulations were carried out as a series of collisions, which occurred when a potential step was encountered 
by a pair of atoms. At such collisions, the atomic velocities were updated following the laws of conservations of 
energy, momentum and angular momentum. For modeling both proteins and small molecules, we employed 
Medusa force field35. The non-bonded inter-atomic interaction included van der Waals, solvation, hydrogen 
bond and electrostatic terms. The van der Waals parameters were adopted from the CHARMM force field57, and 
bonded termed were parameterized based on statistical analysis of protein structures from protein data bank 
(PDB) values. The water molecules were implicitly modeled using the EEF1 implicit solvation model developed 
by Lazaridis and Karplus58. A reaction-like algorithm was used to model hydrogen bonds59. The electrostatic 
interactions were screened using the Debye-Hückel approximation with screening length set to 10 Å, which cor-
responds to 100 mM of NaCl. The force field in all-atom DMD is physics-based and transferrable. The same 
force field has been shown to be able to accurately predict small-molecule ligand-receptor binding poses and 
estimate binding affinities60,61. Using all-atom DMD simulations, we were able to accurately model the structure 
and dynamics of polymeric PAMAM nanoparticles62 and their interactions with both linear and polyaromatic 
small molecule hydrocarbons63.
Simulation Setup. The initial atomic structure of monomer IAPP was obtained from the protein data bank 
(PDB code 2L8664). The disulfide bond between residues 2 and 7 strongly influence the structure and aggregation 
of IAPP32,65. Hence we treated the disulfide bond as a covalent bond and kept it intact in simulations. We simu-
lated different systems consisting of 1, 2, 4, 6 or 8 IAPP chains with two small molecules per IAPP chain. The sim-
ulations were performed in cubic boxes whose size was varied such that the density of IAPPs was approximately 
the same for all the systems. The sizes of the smallest (one IAPP) and largest (eight IAPPs) boxes were 63.7 Å and 
127.3 Å, respectively. Simulations were set up by randomly placing IAPP(s) and small molecules inside the box. 
For the simulation of small molecules without IAPP, 16 small molecules were placed in a cubic box of size 127.3 Å. 
To improve sampling and remove any possible bias arising from the initial structure, ten independent simulations 
were carried out for each molecular system, in which the initial molecular positions, orientations, and atomic 
velocities were randomized using random number generation with different random seeds. The systems were 
first energy minimized for 1,000 steps using steepest descent algorithm, and then equilibrium simulations were 
carried out for one million DMD steps, which corresponds to a simulation time of ~50 ns. The temperature of the 
system was maintained at ~300K using Anderson thermostat66. Our analysis showed that the simulations reached 
steady state after about 25 ns, so the averaging of quantities was done over the last half of simulations.
Clustering. The clustering analysis of IAPP and small molecules was based on pairwise contacts between 
molecules. At any instance, two molecules were defined to be in contact if the distance between any two 
inter-molecular atoms was smaller than 5.5 Å. If two molecules were directly in contact, or they were connected 
through contacts with one or more other molecules, they were defined to be in the same cluster.
Dynamic Light Scattering Measurement. Human IAPP (KCNTATCATQRLANFLVHSSNNF 
GAILSSTNVGSNTY; modifications: Tyr-37 – C-terminal amide, disulfide bridge between cysteines 2 and 
7; C165H261N51O55S2; MW: 3,903; purity: > 95%) was purchased in lyophilized powder form from Abcam 
(www.abcam.com). Resveratrol was obtained in lyophilized powder form from Sigma-Aldrich (purity: 99%). 
The resveratrol was first dissolved in ethanol to 10 mg/mL and further diluted in Milli-Q water to reach a stock 
concentration of 0.02 mg/mL or 87 μ M, well below the known resveratrol water solubility of 131 μ M. The IAPP 
was weighed on a Cubis MSE (Sartorius) balance with 0.01 mg resolution and then dissolved in Milli-Q water to 
form a 0.25 mg/mL (64 μ M) stock solution immediately prior to the DLS measurement.
High-throughput DLS. The hydrodynamic sizes of IAPP and IAPP-resveratrol mixtures were acquired at room 
temperature using an automated, high-throughput DLS device (DynaPro Plate Reader, Wyatt; instrument resolu-
tion: 0.5 nm) and black 384-well plates (Thermo Fisher). For each sample well, the volume of the protein was fixed 
at 6 μ L while the volume of resveratrol was varied from 0 μ L (IAPP control) to 9 μ L, 12 μ L and 14 μ L. Each sample 
volume was then topped up to 20 μ L with Milli-Q water, rendering an IAPP/resveratrol molar ratio of 1:2, 1:2.7 
and 1:3.1, respectively. In addition, the resveratrol control (39 μ M) constituted 9 μ L of the small-molecule stock 
and 11 μ L of Milli-Q water. The selection of these sample conditions ensured that the final IAPP concentration 
in each sample well (19 μ M) was favorable for amyloid aggregation, resveratrol (up to 59 μ M) was well dissolved, 
and the signals were sufficiently strong for detection. Prior to the measurement, the samples were spun for 1 min 
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at 1,000 rpm/164 RCF (Centrifuge 5804, Eppendorf) to ensure good mixing. An optical module collected 20 
data points for each sample well while scanning through all samples continuously. The acquired data were auto-
matically processed and displayed using the Dynamics 7.1.7 software. To ensure repeatability and statistics each 
sample condition was measured in quadruplicate. The experiment ran for 450 min in total.
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